{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T04:59:30Z","timestamp":1782968370703,"version":"3.54.5"},"reference-count":27,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["R01AA015974"],"award-info":[{"award-number":["R01AA015974"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000867","name":"Robert Wood Johnson Foundation","doi-asserted-by":"publisher","award":["65111"],"award-info":[{"award-number":["65111"]}],"id":[{"id":"10.13039\/100000867","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010232","name":"National Institute of Development Administration","doi-asserted-by":"publisher","award":["R01DA13110"],"award-info":[{"award-number":["R01DA13110"]}],"id":[{"id":"10.13039\/501100010232","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010232","name":"National Institute of Development Administration","doi-asserted-by":"publisher","award":["R01DA14482"],"award-info":[{"award-number":["R01DA14482"]}],"id":[{"id":"10.13039\/501100010232","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000867","name":"Robert Wood Johnson Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000867","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Addictive Behaviors"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.addbeh.2011.01.032","type":"journal-article","created":{"date-parts":[[2011,1,28]],"date-time":"2011-01-28T04:29:52Z","timestamp":1296188992000},"page":"584-589","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":135,"title":["Using medication-assisted treatment for substance use disorders: Evidence of barriers and facilitators of implementation"],"prefix":"10.1016","volume":"36","author":[{"given":"Paul M.","family":"Roman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda J.","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah K.","family":"Knudsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addbeh.2011.01.032_bb0005","doi-asserted-by":"crossref","first-page":"628","DOI":"10.15288\/jsad.2009.70.628","article-title":"Counselor attitudes toward pharmacotherapies for alcohol dependence","volume":"70","author":"Abraham","year":"2009","journal-title":"Journal of Studies on Alcohol and Drugs"},{"key":"10.1016\/j.addbeh.2011.01.032_bb0010","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jsat.2010.01.003","article-title":"The adoption of alcohol pharmacotherapies in the Clinical Trials Network: The influence of research network participation","volume":"38","author":"Abraham","year":"2010","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.addbeh.2011.01.032_bb0015","doi-asserted-by":"crossref","first-page":"460","DOI":"10.15288\/jsad.2010.71.460","article-title":"Early adoption of injectable naltrexone for alcohol use disorders: Findings from the private treatment sector","volume":"71","author":"Abraham","year":"2010","journal-title":"Journal of Studies on Alcohol and Drugs"},{"key":"10.1016\/j.addbeh.2011.01.032_bb0020","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1097\/01.jcp.0000246209.18777.14","article-title":"Trends in the adoption of medications for alcohol dependence","volume":"26","author":"Ducharme","year":"2006","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.addbeh.2011.01.032_bb0025","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jsat.2006.05.021","article-title":"Innovation adoption in substance abuse treatment: Exposure, trialability, and the Clinical Trials Network","volume":"32","author":"Ducharme","year":"2007","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.addbeh.2011.01.032_bb0130","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1056\/NEJMoa055255","article-title":"Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence","volume":"355","author":"Fiellin","year":"2006","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.addbeh.2011.01.032_bb0135","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0740-5472(02)00269-6","article-title":"Putting drug abuse research to use in real-life settings","volume":"23","author":"Hanson","year":"2002","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.addbeh.2011.01.032_bb0030","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jsat.2008.12.004","article-title":"Buprenorphine adoption in the National Drug Abuse Treatment Clinical Trials Network","volume":"37","author":"Knudsen","year":"2009","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.addbeh.2011.01.032_bb0035","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jsat.2006.03.013","article-title":"Early adoption of buprenorphine in substance abuse treatment centers: Data from the private and public sectors","volume":"30","author":"Knudsen","year":"2006","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.addbeh.2011.01.032_bb0040","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.drugalcdep.2006.08.013","article-title":"The adoption of medications in substance abuse treatment: Associations with organizational characteristics and technology clusters","volume":"87","author":"Knudsen","year":"2007","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.addbeh.2011.01.032_bb0045","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jsat.2005.05.002","article-title":"Buprenorphine diffusion: The attitudes of substance abuse treatment counselors","volume":"29","author":"Knudsen","year":"2005","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.addbeh.2011.01.032_bb0050","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1177\/002204260503500308","article-title":"Organizational predictors of pharmacological innovation adoption: The case of disulfiram","volume":"35","author":"Knudsen","year":"2005","journal-title":"Journal of Drug Issues"},{"key":"10.1016\/j.addbeh.2011.01.032_bb0055","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/ADM.0b013e3181b41a32","article-title":"Facilitating factors and barriers to the use of medications in publicly funded addiction treatment organizations","volume":"4","author":"Knudsen","year":"2010","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.addbeh.2011.01.032_bb0060","unstructured":"Knudsen, H.K., Abraham, A.J., & Oser, C.B. (under review). Barriers to the implementation of medication-assisted treatment for substance use disorder: The important of funding policies and medical infrastructure. Evaluation and Program Planning."},{"key":"10.1016\/j.addbeh.2011.01.032_bb0065","series-title":"Patient placement criteria for the treatment of substance-related disorders","author":"Mee-Lee","year":"2006"},{"key":"10.1016\/j.addbeh.2011.01.032_bb0105","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s11414-008-9108-4","article-title":"Improving care for the treatment of alcohol and drug disorders","volume":"36","author":"McCarty","year":"2009","journal-title":"Journal of Behavioral Health Services & Research"},{"key":"10.1016\/j.addbeh.2011.01.032_bb0110","first-page":"215","article-title":"Quality management in a health care setting: A study of substance abuse treatment centers","volume":"5","author":"Milne","year":"2000","journal-title":"Advances in the Management of Organizational Quality"},{"key":"10.1016\/j.addbeh.2011.01.032_bb0115","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jsat.2005.01.004","article-title":"Influence of psychotherapy attendance on buprenorphine treatment outcome","volume":"28","author":"Montoya","year":"2000","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.addbeh.2011.01.032_bb0120","series-title":"Principles of drug addiction treatment: A research-based guide (Publication 00-4180)","author":"National Institute on Drug Abuse","year":"2000"},{"key":"10.1016\/j.addbeh.2011.01.032_bb0125","unstructured":"National Quality Forum. (2007). National voluntary consensus standards for the treatment of substance use conditions: Evidence-based treatment practices. Retrieved on January 4, 2011. Available online at: http:\/\/www.qualityforum.org\/Publications\/2007\/09\/National_Voluntary_Consensus_Standards_for_the_Treatment_of_Substance_Use_Conditions__Evidence-Based_Treatment_Practices.aspx"},{"key":"10.1016\/j.addbeh.2011.01.032_bb0070","doi-asserted-by":"crossref","first-page":"56","DOI":"10.7326\/0003-4819-154-1-201101040-00008","article-title":"Integrating addiction medicine into graduate medical education in primary care: The time has come","volume":"154","author":"O'Connor","year":"2011","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.addbeh.2011.01.032_bb0075","doi-asserted-by":"crossref","first-page":"852","DOI":"10.15288\/jsad.2007.68.852","article-title":"Organizational-level predictors of adoption across time: naltrexone in private substance-use disorders treatment centers","volume":"68","author":"Oser","year":"2007","journal-title":"Journal of Studies on Alcohol and Drugs"},{"key":"10.1016\/j.addbeh.2011.01.032_bb0080","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jsat.2007.08.003","article-title":"A categorical typology of naltrexone-adopting private substance abuse treatment centers","volume":"34","author":"Oser","year":"2008","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.addbeh.2011.01.032_bb0085","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1016\/j.jsat.2009.12.008","article-title":"A longitudinal study of organizational formation, innovation adoption, and dissemination activities within the National Drug Abuse Treatment Clinical Trials Network","volume":"38","author":"Roman","year":"2010","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.addbeh.2011.01.032_bb0090","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0740-5472(02)00241-6","article-title":"Adoption and implementation of new technologies in substance abuse treatment","volume":"22","author":"Roman","year":"2002","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.addbeh.2011.01.032_bb0095","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.drugalcdep.2004.12.008","article-title":"The practice of office-based buprenorphine treatment of opioid dependence: Is it associated with new patients entering into treatment?","volume":"79","author":"Sullivan","year":"2005","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.addbeh.2011.01.032_bb0100","series-title":"Slaying the dragon: The history of addiction treatment and recovery in America","author":"White","year":"1998"}],"container-title":["Addictive Behaviors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306460311000554?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306460311000554?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T18:31:34Z","timestamp":1759689094000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306460311000554"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0306460311000554"],"URL":"https:\/\/doi.org\/10.1016\/j.addbeh.2011.01.032","relation":{},"ISSN":["0306-4603"],"issn-type":[{"value":"0306-4603","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Using medication-assisted treatment for substance use disorders: Evidence of barriers and facilitators of implementation","name":"articletitle","label":"Article Title"},{"value":"Addictive Behaviors","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addbeh.2011.01.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}